(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate(CAS: 87980-68-5)

This compound is a highly structured cyclic ether with a molecular weight of approximately 402.42 g/mol. It is practically insoluble in water but soluble in organic solvents like methanol and acetone. The compound exhibits limited reactivity, primarily in its characteristic ring-opening reactions. It crystallizes in a specific form that is stable under standard laboratory conditions.

This compound is synthesized through a multi-step process involving the ring-closing metathesis of a linear diene followed by selective hydroxylation and methylation steps. The synthesis often employs ruthenium-based catalysts and is optimized for high yield and selectivity. Detailed procedures are available in various academic and patent literature.

This compound is primarily used in the pharmaceutical industry for its unique chemical structure, which can be incorporated into drug formulations. It is also explored for its potential in the polymer industry for developing specialized materials. Additionally, it has applications in sensor technology due to its sensing properties and in semiconductor manufacturing for specific processing steps.

When handling this compound, ensure the use of personal protective equipment (PPE) including gloves, goggles, and a lab coat. Work in a well-ventilated area or fume hood to minimize exposure. Spills should be handled with care using appropriate absorbents, and the material safety data sheet (MSDS) should be consulted for specific disposal instructions. Avoid inhaling the vapors and do not ingest or come into contact with skin or eyes.